COVIVIO (COV.PA) Fundamental Analysis & Valuation

EPA:COV • FR0000064578

58.45 EUR
+0.75 (+1.3%)
Last: Mar 4, 2026, 07:00 PM

This COV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, COV scores 3 out of 10 in our fundamental rating. COV was compared to 43 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. COV.PA Profitability Analysis

1.1 Basic Checks

  • COV had positive earnings in the past year.
  • COV had a positive operating cash flow in the past year.
  • COV had positive earnings in 4 of the past 5 years.
  • COV had a positive operating cash flow in 4 of the past 5 years.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • COV's Return On Assets of 1.63% is in line compared to the rest of the industry. COV outperforms 46.51% of its industry peers.
  • The Return On Equity of COV (5.08%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.21%, COV perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • COV has a Profit Margin (30.46%) which is in line with its industry peers.
  • COV's Profit Margin has improved in the last couple of years.
  • COV has a worse Operating Margin (57.81%) than 60.47% of its industry peers.
  • COV's Operating Margin has improved in the last couple of years.
  • COV has a Gross Margin (74.42%) which is comparable to the rest of the industry.
  • COV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
OM growth 3Y11.41%
OM growth 5Y7.53%
PM growth 3Y16.3%
PM growth 5Y17.87%
GM growth 3Y2.18%
GM growth 5Y0.71%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1

2. COV.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COV is destroying value.
  • There is no outstanding debt for COV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • COV has an Altman-Z score of 0.54. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
  • COV's Altman-Z score of 0.54 is on the low side compared to the rest of the industry. COV is outperformed by 67.44% of its industry peers.
  • The Debt to FCF ratio of COV is 28.49, which is on the high side as it means it would take COV, 28.49 years of fcf income to pay off all of its debts.
  • COV has a Debt to FCF ratio of 28.49. This is in the lower half of the industry: COV underperforms 65.12% of its industry peers.
  • COV has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • COV has a worse Debt to Equity ratio (1.07) than 74.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Altman-Z 0.54
ROIC/WACC0.55
WACC5.86%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
  • With a decent Current ratio value of 0.76, COV is doing good in the industry, outperforming 65.12% of the companies in the same industry.
  • COV has a Quick Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • COV has a better Quick ratio (0.69) than 65.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. COV.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.26% over the past year.
  • Measured over the past 5 years, COV shows a small growth in Earnings Per Share. The EPS has been growing by 2.44% on average per year.
  • COV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.71%.
  • Measured over the past years, COV shows a decrease in Revenue. The Revenue has been decreasing by -2.03% on average per year.
EPS 1Y (TTM)6.26%
EPS 3Y1.22%
EPS 5Y2.44%
EPS Q2Q%6.28%
Revenue 1Y (TTM)-11.71%
Revenue growth 3Y-8.88%
Revenue growth 5Y-2.03%
Sales Q2Q%40.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.19% on average over the next years.
  • Based on estimates for the next years, COV will show a small growth in Revenue. The Revenue will grow by 5.15% on average per year.
EPS Next Y0.64%
EPS Next 2Y2.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.51%
Revenue Next 2Y5.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. COV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.31, COV is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 67.44% of the companies listed in the same industry.
  • COV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
  • The Price/Forward Earnings ratio is 12.23, which indicates a correct valuation of COV.
  • The rest of the industry has a similar Price/Forward Earnings ratio as COV.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. COV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.31
Fwd PE 12.23
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 62.79% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of COV indicates a slightly more expensive valuation: COV is more expensive than 60.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.62
EV/EBITDA 17.23
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)19.27
PEG (5Y)5.04
EPS Next 2Y2.19%
EPS Next 3YN/A

4

5. COV.PA Dividend Analysis

5.1 Amount

  • COV has a Yearly Dividend Yield of 6.11%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.12, COV pays a bit more dividend than its industry peers.
  • COV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.11%

5.2 History

  • The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • COV pays out 92.76% of its income as dividend. This is not a sustainable payout ratio.
DP92.76%
EPS Next 2Y2.19%
EPS Next 3YN/A
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

COV.PA Fundamentals: All Metrics, Ratios and Statistics

COVIVIO

EPA:COV (3/4/2026, 7:00:00 PM)

58.45

+0.75 (+1.3%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)07-20
Inst Owners42.11%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.52B
Revenue(TTM)1.15B
Net Income(TTM)417.86M
Analysts75
Price Target64.28 (9.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.11%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.76%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.66%
PT rev (3m)-0.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 12.31
Fwd PE 12.23
P/S 4.76
P/FCF 16.62
P/OCF 6.5
P/B 0.79
P/tB 0.83
EV/EBITDA 17.23
EPS(TTM)4.75
EY8.13%
EPS(NY)4.78
Fwd EY8.18%
FCF(TTM)3.52
FCFY6.02%
OCF(TTM)8.99
OCFY15.38%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)19.27
PEG (5Y)5.04
Graham Number88.73
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
FCFM 28.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y11.41%
OM growth 5Y7.53%
PM growth 3Y16.3%
PM growth 5Y17.87%
GM growth 3Y2.18%
GM growth 5Y0.71%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Debt/EBITDA 9.39
Cap/Depr 415.79%
Cap/Sales 44.53%
Interest Coverage 250
Cash Conversion 106.76%
Profit Quality 93.95%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.54
F-Score7
WACC5.86%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.26%
EPS 3Y1.22%
EPS 5Y2.44%
EPS Q2Q%6.28%
EPS Next Y0.64%
EPS Next 2Y2.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.71%
Revenue growth 3Y-8.88%
Revenue growth 5Y-2.03%
Sales Q2Q%40.47%
Revenue Next Year4.51%
Revenue Next 2Y5.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y1.52%
EBIT growth 5Y5.34%
EBIT Next Year7.68%
EBIT Next 3Y7.22%
EBIT Next 5YN/A
FCF growth 1Y-30.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.27%
OCF growth 3YN/A
OCF growth 5YN/A

COVIVIO / COV.PA FAQ

Can you provide the ChartMill fundamental rating for COVIVIO?

ChartMill assigns a fundamental rating of 3 / 10 to COV.PA.


What is the valuation status for COV stock?

ChartMill assigns a valuation rating of 4 / 10 to COVIVIO (COV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for COVIVIO?

COVIVIO (COV.PA) has a profitability rating of 4 / 10.


What is the financial health of COVIVIO (COV.PA) stock?

The financial health rating of COVIVIO (COV.PA) is 1 / 10.


How sustainable is the dividend of COVIVIO (COV.PA) stock?

The dividend rating of COVIVIO (COV.PA) is 4 / 10 and the dividend payout ratio is 92.76%.